Table 3.

Clinical and laboratorial finds of HIV seropositive individuals investigated for VL in three referral hospitals in Pernambuco, Brazil, and results from the univariate analysis of the comparison between the HIV/VL coinfected and HIV mono-infected groups

Variables	Total	HIV-VL	HIV	P value
Symptoms
Fever	140/206 (67.63%)	24 (70.59%)	116 (67.44%)	0.719
Time of fever (in days)*	11.69 ± 11.44	11.47 ± 12.08	11.74 ± 11.37	0.948
Shortness of breath	101/206 (49.03%)	16 (47.06%)	85 (49.42%)	0.801
Bleeding	30/206 (14.56%)	6 (17.65%)	24 (13.95%)	0.577
Cough	114/206 (55.34)	18 (52.94%)	96 (55.81%)	0.758
Diarrhea	97/206 (47.09%)	16 (47.06%)	81 (47.09%)	0.997
Loss of weight	152/201 (75.62%)	24 (70.59%)	128 (76.65%)	0.453
Loss of weight (kg)*	8.11 ± 4.95	7 ± 5.67	8.33 ± 4.80	0.110
Hepatomegaly	25/139 (17.99%)	3 (11.54%)	22 (19.47%)	0.342
Splenomegaly	14/139 (10.07%)	1 (3.85%)	13 (11.50%)	0.242
Rarefaction of hair	49/189 (25.93%)	6 (20.00%)	43 (27.04%)	0.419
Pallor	84/187 (44.92%)	20 (66.67%)	64 (40.76%)	0.009†
Laboratorial results*
Leukocytes	5,993 ± 4,321	5,720 ± 3,484	6,054 ± 4,494	0.956
Neutrophils	4,054 ± 3,344	3,762 ± 2,760	4,121 ± 3,468	0.607
Lymphocytes	1,049 ± 825	1,072 ± 747	1,044 ± 843	0.499
Hemoglobin	10.03 ± 2.32	10.51 ± 2.53	9.92 ± 2.26	0.214
Hematocrit	29.89 ± 6.78	31.57 ± 7.41	29.51 ± 6.59	0.114
Platelets (×103)	235.591 ± 135.871	244.9 ± 139	233.4 ± 135	0.627
AST	68.39 ± 103.74	54.72 ± 54.84	71.28 ± 111.3	0.367
ALT	58.60 ± 88.90	46.96 ± 45.42	61.00 ± 95.38	0.359
Urea	35.68 ± 27.21	32.47 ± 18.09	36.36 ± 28.80	0.987
Creatinine	0.97 ± 1.05	0.87 ± 0.53	0.98 ± 1.12	0.618
Albumin	3.13 ± 0.88	3.57 ± 0.79	3.01 ± 0.87	0.009†

VL = Visceral leishmaniasis.

^*Mean ± standard deviation.

^†Statistically significant difference (P < 0.05).